4//SEC Filing
Kim Hyung Heon 4
Accession 0001104659-24-088925
CIK 0001638287other
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 4:01 PM ET
Size
5.3 KB
Accession
0001104659-24-088925
Insider Transaction Report
Form 4
Kim Hyung Heon
DirectorCEO & President
Transactions
- Tax Payment
Common Stock
2024-08-11$3.60/sh−11,467$41,281→ 66,666 total
Footnotes (2)
- [F1]Shares were withheld by the Issuer in satisfaction of the Reporting Person's tax liabilities in connection with the vesting of restricted stock units, based on the Issuer's closing price on August 9, 2024.
- [F2]The total number of securities beneficially owned has been adjusted to reflect the Issuer's completion of a 1-for-8 reverse stock split on December 20, 2023.
Documents
Issuer
NeuroBo Pharmaceuticals, Inc.
CIK 0001638287
Entity typeother
Related Parties
1- filerCIK 0001873258
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 4:01 PM ET
- Size
- 5.3 KB